M. Axelson

6.4k total citations · 2 hit papers
68 papers, 5.3k citations indexed

About

M. Axelson is a scholar working on Molecular Biology, Spectroscopy and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, M. Axelson has authored 68 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 19 papers in Spectroscopy and 16 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in M. Axelson's work include Analytical Chemistry and Chromatography (19 papers), Drug Transport and Resistance Mechanisms (13 papers) and Cholesterol and Lipid Metabolism (10 papers). M. Axelson is often cited by papers focused on Analytical Chemistry and Chromatography (19 papers), Drug Transport and Resistance Mechanisms (13 papers) and Cholesterol and Lipid Metabolism (10 papers). M. Axelson collaborates with scholars based in Sweden, United Kingdom and Germany. M. Axelson's co-authors include Jan Sjövall, Kenneth D.R. Setchell, D. N. KIRK, S. P. Borriello, K.D.R. Setchell, A. M. Lawson, Johanna Sjövall, Bengt E. Gustafsson, P Röbel and C. Corpéchot and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

M. Axelson

67 papers receiving 5.0k citations

Hit Papers

Characterization and meas... 1981 2026 1996 2011 1981 1984 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
M. Axelson 2.1k 1.6k 1.4k 1.1k 882 68 5.3k
Shozo Yamamoto 614 0.3× 2.6k 1.7× 509 0.4× 680 0.6× 325 0.4× 153 7.0k
Bo Carlsson 2.6k 1.2× 2.1k 1.3× 1.6k 1.2× 5.1k 4.6× 996 1.1× 13 8.3k
Bao Ting Zhu 693 0.3× 2.6k 1.6× 588 0.4× 1.7k 1.5× 836 0.9× 160 6.6k
Natsuo Ueda 1.2k 0.6× 2.2k 1.4× 1.4k 1.0× 400 0.4× 260 0.3× 155 8.9k
Angelo Benedetti 486 0.2× 2.5k 1.6× 492 0.4× 283 0.3× 264 0.3× 138 5.3k
Anna Colell 1.2k 0.6× 4.9k 3.1× 511 0.4× 180 0.2× 541 0.6× 93 8.8k
Josephine G. Lemmen 1.7k 0.8× 894 0.6× 593 0.4× 1.9k 1.7× 420 0.5× 13 4.1k
Hiroaki Takayama 1.5k 0.7× 908 0.6× 580 0.4× 849 0.8× 156 0.2× 224 4.4k
Jordan K. Zjawiony 914 0.4× 1.7k 1.1× 424 0.3× 457 0.4× 160 0.2× 135 4.8k
James P. Hardwick 467 0.2× 2.0k 1.3× 608 0.4× 308 0.3× 1.3k 1.5× 78 5.3k

Countries citing papers authored by M. Axelson

Since Specialization
Citations

This map shows the geographic impact of M. Axelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Axelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Axelson more than expected).

Fields of papers citing papers by M. Axelson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Axelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Axelson. The network helps show where M. Axelson may publish in the future.

Co-authorship network of co-authors of M. Axelson

This figure shows the co-authorship network connecting the top 25 collaborators of M. Axelson. A scholar is included among the top collaborators of M. Axelson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Axelson. M. Axelson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koyama, Takahiko, Apurvasena Parikh, Rachel Galot, et al.. (2025). 1016eTiP A first-in-human phase I study of LY4066434, a potent and orally bioavailable pan-KRAS inhibitor, in KRAS-mutant solid tumors (Trial in Progress). Annals of Oncology. 36. S620–S621.
2.
Yin, Shengli, Ada Girnita, Thomas Strömberg, et al.. (2009). Targeting the insulin-like growth factor-1 receptor by picropodophyllin as a treatment option for glioblastoma. Neuro-Oncology. 12(1). 19–27. 80 indexed citations
3.
Henríquez‐Hernández, Luis Alberto, Amilcar Flores‐Morales, M. Axelson, et al.. (2006). Role of Pituitary Hormones on 17α-Ethinylestradiol-Induced Cholestasis in Rat. Journal of Pharmacology and Experimental Therapeutics. 320(2). 695–705. 28 indexed citations
4.
Girnita, Ada, Weng‐Onn Lui, Radu Vasilcanu, et al.. (2005). The insulin-like growth factor-1 receptor inhibitor PPP produces only very limited resistance in tumor cells exposed to long-term selection. Oncogene. 25(22). 3186–3195. 40 indexed citations
5.
Catrina, Sergiu‐Bogdan, Moira Lewitt, Charles Massambu, et al.. (2005). Insulin-like growth factor-I receptor activity is essential for Kaposi's sarcoma growth and survival. British Journal of Cancer. 92(8). 1467–1474. 26 indexed citations
6.
Lütjohann, Dieter, Christian Hahn, Thomas Sudhop, et al.. (2004). Influence of rifampin on serum markers of cholesterol and bile acid synthesis in men. International Journal of Clinical Pharmacology and Therapeutics. 42(6). 307–313. 30 indexed citations
7.
Weinbrenner, Tanja, Georg E. Jacoby, S. Herpertz, et al.. (2004). Lipoprotein metabolism in patients with anorexia nervosa: a case–control study investigating the mechanisms leading to hypercholesterolaemia. British Journal Of Nutrition. 91(6). 959–969. 49 indexed citations
8.
Sigurjónsdóttir, Helga Ágústa, Karin Manhem, M. Axelson, & Susanna M. Wallerstedt. (2003). Subjects with essential hypertension are more sensitive to the inhibition of 11 β-HSD by liquorice. Journal of Human Hypertension. 17(2). 125–131. 32 indexed citations
9.
Einarsson, Curt, Carl-Gustaf Hillebrant, & M. Axelson. (2001). Effects of Treatment With Deoxycholic Acid and Chenodeoxycholic Acid on the Hepatic Synthesis of Cholesterol and Bile Acids in Healthy Subjects. Hepatology. 33(5). 1189–1193. 24 indexed citations
10.
Axelson, M., Ewa Ellis, Birgitta Mörk, et al.. (2000). Bile acid synthesis in cultured human hepatocytes: support for an alternative biosynthetic pathway to cholic acid. Hepatology. 31(6). 1305–1312. 74 indexed citations
11.
Hillebrant, Carl-Gustaf, Björn Nyberg, Bo Angelin, et al.. (1999). Deoxycholic acid treatment in patients with cholesterol gallstones: failure to detect a suppression of cholesterol
7α‐hydroxylase activity. Journal of Internal Medicine. 246(4). 399–407. 13 indexed citations
12.
Axelson, M., et al.. (1998). The level of 7-dehydrocholesterol in plasma reflects the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase in the human liver. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1394(2-3). 153–157. 9 indexed citations
13.
Gustafsson, Ulf, et al.. (1997). The effect of vitamin C in high doses on plasma and biliary lipid composition in patients with cholesterol gallstones: prolongation of the nucleation time. European Journal of Clinical Investigation. 27(5). 387–391. 21 indexed citations
14.
Li, Meng, Humberto Reyes, M. Axelson, et al.. (1997). Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: Effect of ursodeoxycholic acid therapy. Hepatology. 26(6). 1573–1579. 91 indexed citations
17.
Anderson, Robert A., Thomas A. Baillie, M. Axelson, et al.. (1990). Stable isotope studies on steroid metabolism and kinetics: sulfates of 3α-hydroxy-5α-pregnane derivatives in human pregnancy. Steroids. 55(10). 443–457. 22 indexed citations
18.
Axelson, M., et al.. (1988). Levels of 7α‐hydroxy‐4‐cholesten‐3‐one in plasma reflect rates of bile acid synthesis in man. FEBS Letters. 239(2). 324–328. 125 indexed citations
19.
Sjövall, Jan & M. Axelson. (1984). Sample work-up by column techniques. Journal of Pharmaceutical and Biomedical Analysis. 2(2). 265–280. 20 indexed citations
20.
Axelson, M., et al.. (1978). Separation and Configuration ofSynandAntiIsomers of Testosterone Oxime. Analytical Letters. 11(3). 229–237. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026